HLA-L: A Protein That Helps Recognize Immune Threats (G3139)

Target Name: HLA-L

NCBI ID: G3139

HLA-L

Other Name(s): HLA92 | HLA-92 | Major histocompatibility complex, class I, L (pseudogene) | HLAL | major histocompatibility complex, class I, L (pseudogene)

HLA-L: A Protein That Helps Recognize Immune Threats

HLA-L (human leukocyte antigen class L) is a protein that is present on the surface of many immune cells, including T cells, B cells, and natural killer cells. It is a type ofHLA class I molecule that is expressed in the human body in large quantities. HLA-L plays a crucial role in the immune system, as it helps to recognize and respond to foreign substances in the body.

HLA-L is a protein that is composed of two heavy chains and one light chain. The heavy chains consists of the variable regions and the joining regions, while the light chain consists of the variable regions and the constant regions. HLA-L is a glycoprotein, which means that it consists of a protein that is composed of both carbohydrates and proteins.

HLA-L is a self-antigen, which means that it is produced by the body and can be recognized by the immune system. HLA-L is present in the human body in large quantities and is expressed in many different tissues and organs, including the skin, hair, and nails. It is also found in the fluid that surrounds the body, such as blood, saliva, and urine.

HLA-L is involved in the immune response by helping to recognize and respond to foreign substances in the body. It is part of the immune system's response to infection and inflammation. When the body is exposed to a foreign substance, such as a virus or bacteria, HLA-L helps to recognize it and initiate an immune response.

HLA-L is also involved in the development and regulation of tissue tolerance. When the immune system is activated, it can cause damage to the body's tissues, which is a normal part of the immune response. However, if the immune system becomes too active or causes too much damage, it can lead to a condition known as autoimmune disease. HLA-L plays a role in regulating the immune response and preventing autoimmune disease.

HLA-L is also a potential drug target. Because HLA-L is involved in the immune response and is present in large quantities in many different tissues and organs, it is an attractive target for drug developers. Researchers are currently working to develop drugs that can inhibit the activity of HLA-L and prevent it from triggering an immune response. These drugs have the potential to be used to treat a wide range of conditions, including autoimmune diseases, cancer, and infections.

Conclusion

HLA-L is a protein that is present in the immune system and plays a crucial role in the immune response. It is also a self-antigen and is involved in the development and regulation of tissue tolerance. As a potential drug target, HLA-L is an attractive target for researchers to develop new treatments for a wide range of conditions.

Protein Name: Major Histocompatibility Complex, Class I, L (pseudogene)

The "HLA-L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HLA-L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets